Yarrow Bioscience (YARW) Short-term Investments (2016 - 2026)

Yarrow Bioscience (YARW) has 10 years of Short-term Investments data on file, last reported at $297000.0 in Q1 2026.

• Quarterly Short-term Investments fell 98.65% year-over-year to $297000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $297000.0 (down 98.65% YoY) and the FY2025 annual result came in at $5.0 million, down 88.02% from the prior year.
• Short-term Investments slipped to $297000.0 in Q1 2026, from $5.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $66.9 million in Q1 2024 to a low of $297000.0 in Q1 2026.
• A 4-year average of $35.4 million and a median of $41.6 million in 2024 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2024 — Short-term Investments plunged 33.6% — and 2026, when it plunged 98.65%.
• Tracing YARW's Short-term Investments over 4 years: stood at $62.6 million in 2023, then slumped by 33.6% to $41.6 million in 2024, then tumbled by 88.02% to $5.0 million in 2025, then sank by 94.04% to $297000.0 in 2026.
• The last three Short-term Investments figures came in at $297000.0 (Q1 2026), $5.0 million (Q4 2025), and $17.6 million (Q2 2025), per Business Quant data.